Disease | chronic myeloproliferative disease |
Symptom | C0836924|thrombocytosis |
Sentences | 2 |
PubMedID- 20586925 | Background: anagrelide is a selective inhibitor of megakaryocytopoiesis used to treat thrombocytosis in patients with chronic myeloproliferative disorders. |
PubMedID- 21312258 | myeloproliferative disorders may present with thrombocytosis and/or leukocytosis with symptoms ranging from minor to life-threatening. |
Page: 1